Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
- Non-exclusive voluntary license agreement enables the manufacture and distribution of lenacapavir for HIV prevention and treatment of heavily treatment-experienced patients with multi drug-resistant HIV HYDERABAD, India, Oct. 2, 2024 /PRNewswire/ -- Hetero, India's leading pharmaceutical company with the widest global reach, today announced a new partnership with Gilead Sciences Ireland UC (Gilead...
South Korea’s SK bioscience Completes Acquisition of Germany’s CDMO IDT Biologika
SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in revenue and infrastructure. The company aims to double sales of IDT Biologika by 2028 through new business projects and operational efficiency. The company will invest in high-growth businesses such...
Zepp Regains Compliance with NYSE Minimum Price Continued Listing Criterion
MILPITAS, Calif., Oct. 2, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated October 2, 2024 (the "October Letter"), notifying the Company that it has regained compliance with the...
APAC LIVER DISEASE ALLIANCE HOSTS “HEP-FREE: ELIMINATING ASIA’S SILENT PUBLIC HEALTH THREAT BY 2030” SUMMIT IN BANGKOK ON 1 OCTOBER 2024
BANGKOK, Oct. 2, 2024 /PRNewswire/ -- The APAC Liver Disease Alliance, in collaboration with Thailand's Department of Disease Control, Ministry of Public Health, kicks off the Alliance's inaugural "Hep-Free: Eliminating Asia's Silent Public Health Threat by 2030" Summit today at The Athenee Hotel, Bangkok. Kamolluck Srisuwankul, Roche, Mihai Irimescu, Roche, Dr. Chatree Jullapetch, MOPH, Dr....
Australia takes centre stage as a cure for Rett Syndrome draws closer
GOLD COAST, Australia, Oct. 2, 2024 /PRNewswire/ -- Australian researcher Associate Professor Wendy Gold, a world leader in Rett Syndrome research from the University of Sydney, joins international colleagues and Rett families on the Gold Coast today to present the latest advances toward a cure.  What is Rett Syndrome? Associate Professor Wendy Gold explains. Wendy will keynote the...
Baird Medical and ExcelFin Acquisition Corp Complete Business Combination
NEW YORK, Oct. 2, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China (which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances), and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ: XFIN), a publicly traded special purpose acquisition company, today...
Astrix Accelerates Global Expansion with Enhanced Presence in Europe
Expanded European presence aims to meet increasing global demand from the life science industry. RED BANK, N.J., Oct. 1, 2024 /PRNewswire/ -- Astrix, the leader in delivering innovative strategies and solutions to the life science community through its market-leading strategic consulting and technology services, is proud to announce its continued momentum and...
PeptiGrowth Inc. is Launching a Novel Synthetic FGF2 Alternative Peptide (FGFR1c Agonist)
TOKYO, Oct. 1, 2024 /PRNewswire/ -- PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo; President: Jiro Sugimoto) has successfully developed a novel synthetic peptide called "FGF2 alternative peptide (FGFR1c agonist)", which has equivalent function to recombinant FGF2 (Fibroblast Growth Factor 2, basic FGF (bFGF)). This product will be on the market at the beginning...
Precision Medicine Group Welcomes Margaret Keegan as CEO
-- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors -- BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider of drug development and commercialization services, today announced the appointment of Margaret Keegan as Chief Executive Officer...
Witsbb’s Nutrient Origin Exploration Garners Over 11 Million Online Likes
SYDNEY, Oct. 1, 2024 /PRNewswire/ -- "Australia, here we come!" Recently, well-known Chinese bloggers @RainbowCouple traveled from China to Australia to embark on a nutrition traceability journey spanning 10,000 kilometers. They visited the headquarters of Witsbb, and their product origin live stream attracted over 4 million viewers online, garnering more than 11 million likes. That day, @RainbowCouple's live stream was...
